Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,577 stories indexed, page 147 of 160

🇺🇸Jan 1, 1970Industryaugmedix.com

Featured signal

Resources New | Augmedix

Publisher

Augmedix

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

AugmedixOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇺🇸Jan 1, 1970Industryaugmedix.com

Resources | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Product Overview | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Business Associate Addendum | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Business Associate Addendum - 2023 Oct 10 | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Augmedix Prep - Product Schedule | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Augmedix Notes - Product Schedule | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Augmedix Live - Product Schedule | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Augmedix Go - Product Schedule | Augmedix

AugmedixOriginal source

🇺🇸Jan 1, 1970Industryaugmedix.com

Archive | Augmedix

AugmedixOriginal source

🌍Jan 1, 1970Industryantidote.me

The Multiple Sclerosis Association of America Proudly Announces the 10th Improving Lives Benefit in Support of the MS Community

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Press Release: Antidote Technologies to present at the 14th annual Tech Tour Growth Health Program

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

PharmaShots: Antidote Technologies and SEQSTER Join Forces to Improve Patient Identification & Enrollment for Clinical Trials

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

IT Digest: Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Endpoints News: "How clinical trial advertising went from old-school tactics to splashy strategies to compete in a fierce market"

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

BTSQ Magazine "Solving Clinical Trial Delays by Accelerating Patient Recruitment"

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Antidote Technologies receives high marks in cybersecurity risk assessment

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Antidote se une a Beyond Type 1 y JDRF para lanzar el primer buscador de ensayos clínicos en español sobre diabetes tipo 1 (DM1)

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Antidote joins forces with Beyond Type 1 and JDRF to launch the first-ever Spanish-language clinical trial search engine for type 1 diabetes (T1D)

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma

Antidote TechnologiesOriginal source

🌍Jan 1, 1970Industryantidote.me

AI TechPark: Antidote announced partnership with SEQSTER

Antidote TechnologiesOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Press releases | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Angelini Pharma at Trento Festival of Economics 2026 | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Sergio Marullo di Condojanni at Trento Festival 2026 | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Rafal Kaminski: Redefining Brain Health Innovation

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Rafal Kaminski on Brain Health Innovation | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

A new Epilepsy Hub for science, care and awareness | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

LIFE-GREENAPI: how innovation and science can support more sustainable API production

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Angelini Pharma hosts the LIFE-GREENAPI final event at its Aprilia plant

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Earth Day 2026: sustainability and long-term impact | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Trento Festival 2026: Marullo on innovation and access | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Angelini Pharma at Reuters Events: Pharma 2026 | Angelini Pharma

Angelini PharmaOriginal source

🇮🇹Jan 1, 1970Industryangelinipharma.com

Media Resources | Angelini Pharma

Angelini PharmaOriginal source

🌍Jan 1, 1970Industryampio.com

industries

Ampio PharmaceuticalsOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

Barry H. Wells, M.D. Joins American Gene Technologies as Head of Business Development

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies® Video Series The Cure Chronicles Wins BioBuzz Media Award

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

AGT Chief Medical Officer Dr. Marcus Conant Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

Dr. Jeff Boyle Appointed as Chief Science Officer for American Gene Technologies

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals

American Gene TechnologiesOriginal source

🇺🇸Jan 1, 1970Industryamericangene.com

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene TechnologiesOriginal source

🇯🇵Jan 1, 1970Regulatoryamed.go.jp

Topics（2026） | Japan Agency for Medical Research and Development

AMED (Japan Agency for Med R&D)Original source

🇯🇵Jan 1, 1970Regulatoryamed.go.jp

R&D Accomplishments(2021) | Japan Agency for Medical Research and Development

AMED (Japan Agency for Med R&D)Original source

🇯🇵Jan 1, 1970Regulatoryamed.go.jp

Majority of Japanese Adults Support Emergency Clinical Research Without Prior Consent, New National Survey Shows | Japan Agency for Medical Research and Development

AMED (Japan Agency for Med R&D)Original source

🇯🇵Jan 1, 1970Regulatoryamed.go.jp

Other（2020） | Japan Agency for Medical Research and Development

AMED (Japan Agency for Med R&D)Original source

🇯🇵Jan 1, 1970Regulatoryamed.go.jp

News Releases & Research Results（2026） | Japan Agency for Medical Research and Development

AMED (Japan Agency for Med R&D)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Transforming intent into action | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

New hope for multiple myeloma patients as breakthrough treatment becomes available | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Increasing accessibility to lifesaving naloxone | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Immunotherapy research centre to boost outcomes for cancer patients | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Harnessing the “teachable, reachable” moment | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Clinicians step into ward redevelopment design | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Celebrating National Volunteers Week | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Celebrating International Clinical Trials Day 2026 | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

Breakthroughs at the cutting edge of phage therapy | Bayside Health (Alfred)

The Alfred (Melbourne)Original source

🇦🇺Jan 1, 1970Researchalfredhealth.org.au

A significant patient renunion | Bayside Health (Alfred)

The Alfred (Melbourne)Original source